⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IVVD News
Invivyd, Inc. Common Stock
Form 8-K
sec.gov
IVVD
Form 8-K
sec.gov
IVVD
Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
IVVD
Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination
globenewswire.com
IVVD
Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026
globenewswire.com
IVVD
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
IVVD
Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit
globenewswire.com
IVVD
Form 8-K
sec.gov
IVVD
Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles
globenewswire.com
IVVD
Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health
globenewswire.com
IVVD